MedPath

Effect of Cemented Stem Design on Periprosthetic Bone Mass Following Primary Total Hip Arthroplasty

Completed
Conditions
Osteoarthritis
Interventions
Procedure: Total Hip Replacement
Registration Number
NCT00293605
Lead Sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Brief Summary

Total hip replacement is a common procedure for the treatment of osteoarthrosis of the hips, the aims of this study are to determine the effect of implant stem design on bone quality surrounding the implant using three stem designs that are routinely implanted at this hospital.

Detailed Description

120 patients will undergo routine hip replacements using either the C-Stem, Exeter Stem or Charnley stem implants. Patients will be clinically evaluated pre-operatively and randomised to one of the three implants. Post-operatively, patients will be clinically reviewed for 2 years using bone mineral density scans, radiological review, blood and urine analysis for bone markers and validated questionnaires to assess clinical data (Oxford Hip and Harries Hip). Patients will be assessed for prothesis migration using the EBRA methods.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • patients must be aged 60 yrs or more uncomplicated primary or secondary osteoarthritis of the hip undergoing unilateral cemented total hip arthroplasty using a metal on polyethylene bearing couple.
Exclusion Criteria
  • metabolic bone disorders, systemic disorders such as rheumatoid arthritis and patients who have taken pharmacological doses of oral steroids, hormone replacement therapy, tamoxifen, calcium or vitamin D supplements within the last year. Patients with a prior history of bisphosphonates and women of child bearing age.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1Total Hip ReplacementC-stem implant
2Total Hip ReplacementCharnley Implant
3Total Hip ReplacementExeter Implant
Primary Outcome Measures
NameTimeMethod
Proximal femoral BMD change over 2 years measured by DXA2 years
Secondary Outcome Measures
NameTimeMethod
Biochemical markers of bone formation and resorption measured from serum and urine samples using the Elecsys system.2 years
Clinical Evaluation using patient centered questionnaire (Oxford Hip Score)2 years
Surgeon centered clinical assessment (Harris Hip Score)2 years
Plain radiographic assessment2 years
Femoral prosthetic stem y-axis migration (subsidence), ans stem/shaft angulation change measured by EBRA.2 years

Trial Locations

Locations (1)

Orthopaedic Department, Northern General Hospital

🇬🇧

Sheffield, South Yorkshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath